Prognostic factors of pain syndrome after uterine artery embolization in women with uterine leiomyoma


Cite item

Abstract

The pain syndrome after uterine artery embolization can vary from slight to very pronounced. Therefore, choosing an adequate method of anesthesia is extremely important in this method of treatment. Aim of the study: pre-operative prognosis of the severity of the pain syndrome and selection of the optimal managing tactics in postoperative period. Materials and methods. Our study includes 65 patients, the patients are divided into 2 groups depending on the method of anesthesia. For analgesia in the perioperative period, the patients of the first group underwent anesthesia by the method of epidural anesthesia (n=44). In the second group (n=21), the operation was performed under local anesthesia. Results. In group 1, the intensity of the pain syndrome was 5.38 on the 1st day, and 2.36 on the 4th day of the postoperative period. In this case, a clear relationship between fibroid size and the severity of the pain syndrome was revealed. In the second group of patients (n=21) on the 1st day of the postoperative period, the average value of the intensity of the pain syndrome was 7.72. On the 4th day of the postoperative period, the average value of the pain syndrome was 4.95. When analyzing the intensity of the pain syndrome, depending on the size of fibroids, a direct correlation was also found in the patients of this group. Conclusion. Pain syndrome depends primarily on the size of the fibroids. Epidural anesthesia can be considered to be the most effective method of anesthesia. The use of epidural anesthesia is especially justified in the presence of large-sized fibroids (>8 cm). It is advisable to discharge patients not earlier than 4 days after the operation, when a reliable control of the intensity of the pain syndrome is achieved.

About the authors

S A Sosin

V.A.Almazov North-West Federal Medical Research Center of the Ministry of Health of the Russian Federation

Email: Sosin_SA@almazovcentre.ru
ассистент каф. акушерства и гинекологии 197341, Russian Federation, Saint Petersburg, ul. Akkuratova, d. 2

V V Privorotskiy

V.A.Almazov North-West Federal Medical Research Center of the Ministry of Health of the Russian Federation

Email: Privorotskiy_VV@almazovcentre.ru
зав. отд-нием рентгенохирургических методов диагностики и лечения 197341, Russian Federation, Saint Petersburg, ul. Akkuratova, d. 2

I E Zazerskaya

V.A.Almazov North-West Federal Medical Research Center of the Ministry of Health of the Russian Federation

Email: Zazerskaya_IE@almazovcentre.ru
д-р мед. наук, зам. дир. по научной работе НИИ перинатологии и педиатрии 197341, Russian Federation, Saint Petersburg, ul. Akkuratova, d. 2

V N Kustarov

V.A.Almazov North-West Federal Medical Research Center of the Ministry of Health of the Russian Federation

Email: Kustarov_VN@almazovcentre.ru
д-р мед. наук, проф. каф. акушерства и гинекологии 197341, Russian Federation, Saint Petersburg, ul. Akkuratova, d. 2

References

  1. Адамян Л.В. и др. Миома матки: диагностика, лечение и реабилитация. Клинические рекомендации по ведению больных. Под ред. Л.В.Адамян (проект). М., 2015.
  2. Ravina J.H, Herbreteau D., Ciraru-Vigneron N. et al. Arterial embolisation to treat uterine myomata. Lancet 1995; 346: 671-2.
  3. Капранов С.А., Бреусенко В.Г., Доброхотова Ю.Э. и др. Эмболизация маточных артерий: современный взгляд на проблему. Часть I: Общие вопросы. Диагностическая и интервенционная радиология. 2007; 1 (1): 72-87.
  4. Schirf B.E, Vogelzang R.L, Chrisman H.B. Complications of Uterine Fibroid Embolization. Semin Intervent Radiol 2006; 23 (2): 143-9. doi: 10.1055/s-2006-941444
  5. Павловская Е.А., Юхно Ю.А., Рязанов В.В. и др. Роль парамагнитных контрастных препаратов в оценке структур малого таза у женщин с лейомиомой матки при планировании эмболизации маточных артерий. Опухоли женской репродуктивной системы. 2014; 3: 64-9
  6. Сосин С.А., Зазерская И.Е. Эмболизация маточных артерий как метод лечения лейомиомы матки. Эффективность и безопасность. Трансляционная медицина. 2011; 6: 20-2.
  7. McCaffery M, Beebe A. Pain: Clinical Manual for Nursing Practice. Baltimore: V.V. Mosby Company, 1993.
  8. Nghia-Jack Vo, Torrance Andrews R. Uterine Artery Embolization: A Safe and Effective, Minimally Invasive, Uterine-Sparing Treatment Option for Symptomatic Fibroids. Semin Intervent Radiol 2008; 25 (3): 252-60. doi: 10.1055/s-0028-1085923
  9. Lampmann L.E, Lohle P.N, Smeets A. et al. Pain Management During Uterine Artery Embolization for Symptomatic Uterine Fibroids. Cardiovasc Intervent Radiol 2007; 30 (4): 809-11. doi: 10.1007/s00270-007-9069-7
  10. Pron G, Mocarski E, Bennett J. et al. Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the Ontario Uterine Fibroid Embolization Trial. J Vasc Interv Radiol 2003; 14: 1243-50.
  11. Bilhim T, Pisco J.M. The Role of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in the Management of the Post-Embolization Symptoms after Uterine Artery Embolization. Pharmaceuticals 2010; 3: 1729-38. doi: 10.3390/ph3061729
  12. Антропова Е.Ю., Коробов В.В. Оценка постэмболизационного синдрома у пациенток с миомой матки. Мед. альманах. 2011; 6: 134-7.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).